Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cancer Res Ther ; 16(2): 350-355, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32474523

RESUMO

The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and their critical morbidity and case fatality rates are high. The ablation expert committee of the Chinese Society of Clinical Oncology compiled corresponding expert recommendations. These recommendations summarize the preventive measures and management of tumor ablation treatment in medical institutions, including outpatient clinics, oncology wards, ablation operation room, and postablation follow-ups in accordance with the guidelines and protocols imposed by the National Health Commission of the People's Republic of China and the experience in management and prevention according to various hospitals. This consensus aims to reduce and prevent the spread of SARS-CoV-2 and its cross-infection between cancer patients in hospitals and provide regulatory advice and guidelines for medical personnel.


Assuntos
Betacoronavirus , Ablação por Cateter/efeitos adversos , Infecções Relacionadas a Cateter/prevenção & controle , Infecções por Coronavirus/prevenção & controle , Surtos de Doenças , Neoplasias/cirurgia , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Guias de Prática Clínica como Assunto/normas , COVID-19 , Infecções Relacionadas a Cateter/virologia , China/epidemiologia , Congressos como Assunto , Infecções por Coronavirus/complicações , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/virologia , Humanos , Neoplasias/patologia , Neoplasias/virologia , Pneumonia Viral/complicações , Pneumonia Viral/epidemiologia , Pneumonia Viral/virologia , SARS-CoV-2
2.
Am J Infect Control ; 47(12): 1500-1504, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31324490

RESUMO

BACKGROUND: Hospital-acquired infections (HAIs) lead to poor health outcomes in hospitalized patients and may be disproportionately affecting the aging population of people living with HIV (PLWH). This study determined the association between HIV and HAIs, and analyzed the potential mediating effects of comorbidities. METHODS: The Louisiana Hospital Inpatient Discharge Database for the years 2011-2015 was used. All patients with at least 1 HAI diagnosis within this source population were included as cases in the case-control study, and a 1:1 ratio of controls was randomly selected from the same hospitals. RESULTS: Of the 1,852,769 eligible hospital discharges that occurred from 2011 through 2015, there were 7,422 patients with at least 1 HAI. Marginal logistic regressions of the case-control sample showed a strong association between HIV and central line-associated bloodstream infections (CLABSIs), but an inverse association between HIV and any HAI. However, the mediation analyses revealed that having at least 1 comorbidity mediates the association between HIV and CLABSIs. DISCUSSION: The unexpected inverse association between HIV and HAI could be attributed to the sample size of the exposed group of patients, or it could be explained by the mechanisms of treatment for HIV patients. CONCLUSIONS: This study found that people living with HIV are at an increased risk of developing a CLABSI, which is consistent with the published literature. The mediation analyses indicated that having at least 1 comorbidity mediated the association between HIV and CLABSI diagnosis.


Assuntos
Doenças Cardiovasculares/epidemiologia , Infecções Relacionadas a Cateter/epidemiologia , Infecção Hospitalar/epidemiologia , Diabetes Mellitus/epidemiologia , Infecções por HIV/epidemiologia , Nefropatias/epidemiologia , Hepatopatias/epidemiologia , Neoplasias/epidemiologia , Adulto , Idoso , Doenças Cardiovasculares/microbiologia , Doenças Cardiovasculares/virologia , Estudos de Casos e Controles , Infecções Relacionadas a Cateter/microbiologia , Infecções Relacionadas a Cateter/virologia , Comorbidade , Infecção Hospitalar/microbiologia , Infecção Hospitalar/virologia , Bases de Dados Factuais , Diabetes Mellitus/microbiologia , Diabetes Mellitus/virologia , Feminino , Infecções por HIV/microbiologia , Infecções por HIV/virologia , Humanos , Nefropatias/microbiologia , Nefropatias/virologia , Hepatopatias/microbiologia , Hepatopatias/virologia , Modelos Logísticos , Louisiana/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias/microbiologia , Neoplasias/virologia , Tamanho da Amostra
3.
Korean J Intern Med ; 30(4): 506-14, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26161017

RESUMO

BACKGROUND/AIMS: Infections are major causes of both early and late death after lung transplantation (LT). The development of prophylaxis strategies has altered the epidemiology of post-LT infections; however, recent epidemiological data are limited. We evaluated infections after LT at our institution by time of occurrence, site of infections, and microbiologic etiologies. METHODS: All consecutive patients undergoing lung or heart-lung transplantation between October 2008 and August 2014 at our institution were enrolled. Cases of infections after LT were initially identified from the prospective registry database, which was followed by a detailed review of the patients' medical records. RESULTS: A total of 108 episodes of post-LT infections (56 bacterial, 43 viral, and nine fungal infections) were observed in 34 LT recipients. Within 1 month after LT, the most common bacterial infections were catheter-related bloodstream infections (42%). Pneumonia was the most common site of bacterial infection in the 2- to 6-month period (28%) and after 6 months (47%). Cytomegalovirus was the most common viral infection within 1 month (75%) and in the 2- to 6-month period (80%). Respiratory viruses were the most common viruses after 6 months (48%). Catheter-related candidemia was the most common fungal infection. Invasive pulmonary aspergillosis developed after 6 months. Survival rates at the first and third years were 79% and 73%, respectively. CONCLUSIONS: Although this study was performed in a single center, we provide valuable and recent detailed epidemiology data for post-LT infections. A further multicenter study is required to properly evaluate the epidemiology of post-LT infections in Korea.


Assuntos
Infecções Bacterianas/microbiologia , Transplante de Coração-Pulmão/efeitos adversos , Transplante de Pulmão/efeitos adversos , Micoses/microbiologia , Viroses/virologia , Adulto , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/mortalidade , Infecções Relacionadas a Cateter/microbiologia , Infecções Relacionadas a Cateter/virologia , Infecções por Citomegalovirus/virologia , Feminino , Transplante de Coração-Pulmão/mortalidade , Humanos , Estimativa de Kaplan-Meier , Transplante de Pulmão/mortalidade , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Micoses/diagnóstico , Micoses/mortalidade , Pneumonia Bacteriana/microbiologia , Sistema de Registros , República da Coreia/epidemiologia , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento , Viroses/diagnóstico , Viroses/mortalidade
4.
Infect Disord Drug Targets ; 13(3): 162-8, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23961738

RESUMO

Hemodialysis (HD) patients are particularly vulnerable to Hepatitis B virus (HBV) and have less sustained and lower antibody response to HBV vaccination. Among blood-borne pathogens, HBV can stay alive on environmental surfaces for over a week. The incidence of HBV was extremely high among HD patients. HBV vaccination, screening of blood products and infection control measures lead to significant decrease of HBV among HD patients. The infection control measures include; Medication safety and injection practices, environmental cleaning and disinfection, reuse of dialyzers for same patients, hand hygiene, isolation and barrier precautions, HBV vaccination and routine serology checking, assuring HBV immune status for HD unit staff, transmission based precautions and outbreak management.


Assuntos
Infecção Hospitalar/prevenção & controle , Hepatite B/prevenção & controle , Controle de Infecções/métodos , Diálise Renal/efeitos adversos , Infecções Relacionadas a Cateter/complicações , Infecções Relacionadas a Cateter/imunologia , Infecções Relacionadas a Cateter/prevenção & controle , Infecções Relacionadas a Cateter/virologia , Infecção Hospitalar/complicações , Infecção Hospitalar/imunologia , Infecção Hospitalar/virologia , Suscetibilidade a Doenças , Hepatite B/complicações , Hepatite B/imunologia , Hepatite B/virologia , Vacinas contra Hepatite B/efeitos adversos , Vacinas contra Hepatite B/imunologia , Vacinas contra Hepatite B/uso terapêutico , Vírus da Hepatite B/crescimento & desenvolvimento , Vírus da Hepatite B/imunologia , Humanos , Controle de Infecções/tendências , Falência Renal Crônica/complicações , Falência Renal Crônica/terapia , Falência Renal Crônica/virologia , Diálise Renal/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...